Manuscripts
Showing 1551 manuscripts.
Immunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-Infected Children and Youth
Citation
PM Flynn, P Muresan, T Fenton, CK Cunningham, W Borkowsky, JB McAuley, SA Spector, E Petzold, W Levy, GK Siberry, E Handelsman, LJ Utech, A Weinberg, RF Pass, S Nachman. Immunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-Infected Children and Youth. 2013. 2: 352-360. PMID: 24363932Year
2013
Study
P1089
Age-Related Differences in Plasma and Intracellular Tenofovir Concentrations in HIV-1 Infected children, adolescents and adults.
Citation
Edward P. Acosta, Courtney V. Fletcher, Gautam Baheti, Jennifer R. King. Age-Related Differences in Plasma and Intracellular Tenofovir Concentrations in HIV-1 Infected children, adolescents and adults.. AIDS. 2013. 27: 221-225. PMID: 23032419Year
2013
Journal
AIDS
Study
P1058A
Feasibility and Safety of ALVAC-HIV vCP1521 Vaccine in HIV- exposed Infants in Uganda: Results from the First HIV Vaccine Trial in Infants in Africa
Citation
Feasibility and Safety of ALVAC-HIV vCP1521 Vaccine in HIV- exposed Infants in Uganda: Results from the First HIV Vaccine Trial in Infants in Africa. Journal of Acquired Immune Deficiency Syndromes. 2013. 63: 1-8. PMID: 23221981Year
2013
Journal
Journal of Acquired Immune Deficiency Syndromes
Genetic Variants in Toll-Like Receptor 2 (TLR2), TLR4, TLR9, and FC¿ Receptor II Are Associated with Antibody Response to Quadrivalent Meningococcal Conjugate Vaccine in HIV-Infected Youth
Citation
Genetic Variants in Toll-Like Receptor 2 (TLR2), TLR4, TLR9, and FC¿ Receptor II Are Associated with Antibody Response to Quadrivalent Meningococcal Conjugate Vaccine in HIV-Infected Youth. Clinical and Vaccine Immunology. 2013. 20: 900-6. PMID: 23595505Year
2013
Journal
Clinical and Vaccine Immunology
Study
P1065
Ethical tradeoffs in trial design: Case study of an HPV vaccine trial in HIV-infected adolescent girls in lower income settings
Citation
Ethical tradeoffs in trial design: Case study of an HPV vaccine trial in HIV-infected adolescent girls in lower income settings. Developmental Pharmacology and Therapeutics. 2013. 13: 95-104. PMID: 23725055Year
2013
Journal
Developmental Pharmacology and Therapeutics
Genetic Variants in the Host Restriction Factor APOBEC3G are Associated with HIV-1 Related Disease Progression and Central
Citation
Genetic Variants in the Host Restriction Factor APOBEC3G are Associated with HIV-1 Related Disease Progression and Central. Journal of Acquired Immune Deficiency Syndromes. 2013. 62: 197-203. PMID: 23138837Year
2013
Journal
Journal of Acquired Immune Deficiency Syndromes
Pubertal Onset in HIV-infected Children in the Era of Combination Antiretroviral Treatment
Citation
Pubertal Onset in HIV-infected Children in the Era of Combination Antiretroviral Treatment. AIDS. 2013. 27: 1959-1970. PMID: 24145244Year
2013
Journal
AIDS
Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy
Citation
Jiajia Wang, Alice Stek, Edmund Capparelli, D Heather Watts, Elizabeth Smith, David E Shapiro, Steve Rossi, Sandra K Burchett, Elizabeth Hawkins, Mark Byroads, Tim R Cressey, Mark Mirochnick, Regis Kreitchmann, Brookie M Best. Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy. Journal of Acquired Immune Deficiency Syndromes. 2013. 63: 59-66. PMID: 23392467Year
2013
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1026S
Safety and Immunogenicity of 2009 pH1N1 Vaccination in HIV-Infected Pregnant Women
Citation
Safety and Immunogenicity of 2009 pH1N1 Vaccination in HIV-Infected Pregnant Women. Clinical Infectious Diseases. 2013. 56: 1488-97. PMID: 23378284Year
2013
Journal
Clinical Infectious Diseases
Study
P1086